Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats - PubMed (original) (raw)
. 2011 Mar 15;251(3):234-44.
doi: 10.1016/j.taap.2011.01.006. Epub 2011 Jan 19.
Affiliations
- PMID: 21255596
- DOI: 10.1016/j.taap.2011.01.006
Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats
Keiichiro Sato et al. Toxicol Appl Pharmacol. 2011.
Abstract
Pioglitazone hydrochloride (PIO), a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, was administered orally for 85 weeks at 16 mg/kg/day to male rats fed either a diet containing 1.5% ammonium chloride (acid-forming diet) or a control diet to investigate the effects of urinary acidification induced by the acid-forming diet on the tumorigenic potential of PIO in the urinary bladder. The surviving animals at the end of the administration period were followed to the end of the 2-year study period without changes in the diet and were subjected to terminal necropsy on Week 104. The number of urinary microcrystals, evaluated by manual counting with light microscopy and by an objective method with a laser diffraction particle size analyzer, was increased by PIO on Weeks 12 and 25 and the increases were markedly suppressed by urinary acidification. Urinary citrate was decreased by PIO throughout the study period, but no changes were seen in urinary oxalate at any timepoint. The incidences of PIO-treated males bearing at least one of the advanced proliferative changes consisting of papillary hyperplasia, nodular hyperplasia, papilloma or carcinoma were significantly decreased from 11 of 82 males fed the control diet to 2 of 80 males fed the acid-forming diet. The acid-forming diet did not show any effects on the toxicokinetic parameters of PIO and its metabolites. Microcrystalluria appears to be involved in the development of the advanced stage proliferative lesions in bladder tumorigenesis induced by PIO in male rats.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
- Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?
Faillie JL, Petit P, Montastruc JL, Hillaire-Buys D. Faillie JL, et al. Drug Saf. 2013 Sep;36(9):693-707. doi: 10.1007/s40264-013-0086-y. Drug Saf. 2013. PMID: 23868339 Review. - Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
Dominick MA, White MR, Sanderson TP, Van Vleet T, Cohen SM, Arnold LE, Cano M, Tannehill-Gregg S, Moehlenkamp JD, Waites CR, Schilling BE. Dominick MA, et al. Toxicol Pathol. 2006;34(7):903-20. doi: 10.1080/01926230601072327. Toxicol Pathol. 2006. PMID: 17178691 - Subchronic urinary bladder effects of muraglitazar in male rats.
Van Vleet TR, White MR, Sanderson TP, Cohen SM, Cano M, Arnold LL, Waites CR, Schilling BE, Mitroka J, Dominick MA. Van Vleet TR, et al. Toxicol Sci. 2007 Mar;96(1):58-71. doi: 10.1093/toxsci/kfl176. Epub 2006 Nov 28. Toxicol Sci. 2007. PMID: 17132713 - Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
Achanzar WE, Moyer CF, Marthaler LT, Gullo R, Chen SJ, French MH, Watson LM, Rhodes JW, Kozlosky JC, White MR, Foster WR, Burgun JJ, Car BD, Cosma GN, Dominick MA. Achanzar WE, et al. Toxicol Appl Pharmacol. 2007 Sep 15;223(3):246-56. doi: 10.1016/j.taap.2007.06.015. Epub 2007 Jul 3. Toxicol Appl Pharmacol. 2007. PMID: 17663016 - Association between pioglitazone and urothelial bladder cancer.
Barbalat Y, Dombrovskiy VY, Weiss RE. Barbalat Y, et al. Urology. 2012 Jul;80(1):1-4. doi: 10.1016/j.urology.2012.03.032. Epub 2012 May 23. Urology. 2012. PMID: 22626574 Review.
Cited by
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis.
Filipova E, Uzunova K, Kalinov K, Vekov T. Filipova E, et al. Diabetes Ther. 2017 Aug;8(4):705-726. doi: 10.1007/s13300-017-0273-4. Epub 2017 Jun 16. Diabetes Ther. 2017. PMID: 28623552 Free PMC article. Review. - DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents.
La Maestra S, Micale RT, De Flora S, D'Agostini F, Ganchev G, Iltcheva M, Petkov N, Steele VE, Balansky R. La Maestra S, et al. Carcinogenesis. 2013 Jan;34(1):183-9. doi: 10.1093/carcin/bgs314. Epub 2012 Oct 5. Carcinogenesis. 2013. PMID: 23042096 Free PMC article. - Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article.
Raana S, Javeed A. Raana S, et al. Iran J Public Health. 2015 Feb;44(2):176-84. Iran J Public Health. 2015. PMID: 25905051 Free PMC article. Review. - Role of γ-H2AX as a biomarker for detection of bladder carcinogens in F344 rats.
Suzuki S, Gi M, Toyoda T, Kato H, Naiki-Ito A, Kakehashi A, Ogawa K, Takahashi S, Wanibuchi H. Suzuki S, et al. J Toxicol Pathol. 2020 Oct;33(4):279-285. doi: 10.1293/tox.2020-0038. Epub 2020 Aug 21. J Toxicol Pathol. 2020. PMID: 33239845 Free PMC article. - Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?
Faillie JL, Petit P, Montastruc JL, Hillaire-Buys D. Faillie JL, et al. Drug Saf. 2013 Sep;36(9):693-707. doi: 10.1007/s40264-013-0086-y. Drug Saf. 2013. PMID: 23868339 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical